Provided by Tiger Trade Technology Pte. Ltd.

Cogent

9.17
-0.8200-8.21%
Post-market: 9.290.1200+1.31%19:59 EDT
Volume:1.86M
Turnover:17.55M
Market Cap:469.65M
PE:-9.73
High:10.16
Open:10.09
Low:9.16
Close:9.99
52wk High:45.69
52wk Low:9.00
Shares:51.22M
Float Shares:45.32M
Volume Ratio:1.00
T/O Rate:4.10%
Dividend:1.08
Dividend Rate:11.72%
EPS(TTM):-0.9421
EPS(LYR):-3.8009
ROE:-721.50%
ROA:-1.24%
PB:-13.76
PE(LYR):-2.41

Loading ...

Cogent Communications Lawsuit Alleges Investor Losses After Wavelength Demand Disclosures

TIPRANKS
·
Jul 30

Cogent CEO Dave Schaeffer to Present at KeyBanc Technology Leadership Forum

Reuters
·
Jul 29

Cogent Communications Schedules Q2 Earnings Call

Reuters
·
Jul 15

Analysts Have Conflicting Sentiments on These Communication Services Companies: Netflix (NFLX) and Cogent Comms (CCOI)

TIPRANKS
·
Jul 09

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

GlobeNewswire
·
Jun 30

Cogent Comms Sells Ten U.S. Data Centers

TIPRANKS
·
Jun 30

Cogent Closes Sale of 10 Data Centers to I Squared Capital-backed Entity for $225 Million Cash

Reuters
·
Jun 30

Cogent Communications Announces Closing of Sale of 10 Data Center Facilities

THOMSON REUTERS
·
Jun 30

Analyst Maintains Buy on Cogent, Keeps Price Target Unchanged at $34 Amid Perceived Upside

TIPRANKS
·
Jun 22

Top Cogent Executive Cashes In on Recent Stock Trade

TIPRANKS
·
Jun 17

Cogent CFO Thaddeus Gerard Weed sells 4,850 common shares for $81,435.41

Reuters
·
Jun 17

Cogent Comms Amends Indenture to Prioritize Debt Reduction

TIPRANKS
·
Jun 16

Cogent Communications VP of Network Strategy Hank Kilmer disposes of 2,400 common shares worth $40,824

Reuters
·
Jun 16

Cogent Communications amends indenture, raises ratio-liens secured leverage cap to 4.75x

Reuters
·
Jun 16

Cogent Biosciences' Potential Rare Blood Disease Treatment Meets Endpoints in Clinical Trial

MT Newswires Live
·
Jun 12

Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

GlobeNewswire
·
Jun 12

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

GlobeNewswire
·
Jun 12

Cogent Biosciences Shareholders Back Board, Governance Proposals

TIPRANKS
·
Jun 12

A Look At Cogent Communications Holdings (CCOI) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 01

Cogent Biosciences announces data from analysis of PEAK Phase 3 trial

TIPRANKS
·
Jun 01